{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-025102","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2024-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.711770+00:00","generated_at":"2026-06-01T02:13:47.756340+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Vivos Therapeutics updates Nasdaq compliance status after $7.5M private placement; hearing June 27","bullets":["Received Nasdaq deficiency notice on May 16, 2024 for failing to meet $2.5M equity requirement.","Completed $7.5M private placement on June 10, 2024; believes it now meets equity requirement.","Hearing before Nasdaq Panel scheduled June 27, 2024; decision expected within 30 days.","Company acknowledges it will need additional equity capital to maintain ongoing compliance.","Risk of delisting if unable to demonstrate compliance; could materially affect stock price."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-025102","json":"https://secwatch.observer/filing/0001493152-24-025102.json","markdown":"https://secwatch.observer/filing/0001493152-24-025102.md","text":"https://secwatch.observer/filing/0001493152-24-025102.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224025102/0001493152-24-025102-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224025102/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:13:47.756340+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}